Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus

Journal of the American Geriatrics Society

Volumn 61, Issue 5, 2013, Pages 734-738

  Cruz Jentoft, Alfonso J ^a   Carpena Ruiz, Marina ^a   Montero Errasquín, Beatriz ^a   Sánchez Castellano, Carmen ^a   Sánchez García, Elisabet ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

ageism; clinical trial; registries; research subject selection; type 2 diabetes mellitus

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN DERIVATIVE; MITIGLINIDE; SULFONYLUREA DERIVATIVE;

ARTICLE; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; HUMAN; LIFE EXPECTANCY; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; POLYPHARMACY; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PATIENT SELECTION; REGISTRIES; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84877962450     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12215     Document Type: Article

References (26)

1. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010; 33: 562-568.
2. Dybicz SB, Thompson S, Molotsky S, et al. Prevalence of diabetes and the burden of comorbid conditions among elderly nursing home residents. Am J Geriatr Pharmacother 2011; 9: 212-223.
3. Hung WW, Ross JS, Boockvar KS, et al. Association of chronic diseases and impairments with disability in older adults: A decade of change? Med Care 2012; 50: 501-507.
4. Sinclair A, Morley JE, Rodriguez-Manas L, et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012; 13: 497-502.
5. Sinclair AJ, Paolisso G, Castro M, et al. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011; 37 (Suppl 3): S27-S38.
6. Brown AF, Mangione CM, Saliba D, et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51: S265-S280.
7. Pratley RE, Gilbert M,. Clinical management of elderly patients with type 2 diabetes mellitus. Postgrad Med 2012; 124: 133-143.
8. Zulman DM, Sussman JB, Chen X, et al. Examining the evidence: A systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 2011; 26: 783-790.
9. Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med 2011; 171: 550-556.
10. Konrat C, Boutron I, Trinquart L, et al. Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS ONE 2012; 7: e33559.
11. Cruz-Jentoft AJ, Gutierrez B,. Upper age limits in studies submitted to a research ethics committee. Aging Clin Exp Res 2010; 22: 175-178.
12. Australian Institute of Health and Welfare 2011. Diabetes Prevalence in Australia: Detailed Estimates for 2007-08. Diabetes series no. 17. Cat. no. CVD 56. Canberra: AIHW.
13. Diabetes in the UK 2011/2012: Key statistics on diabetes. Diabetes UK [on-line]. Available at www.diabetes.org.uk/Documents/About%20Us/Our%20impact/ AnnualReport2012Web.pdf Accessed November 13, 2012.
14. Van Spall HG, Toren A, Kiss A, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. JAMA 2007; 297: 1233-1240.
15. Dodd KS, Saczynski JS, Zhao Y, et al. Exclusion of older adults and women from recent trials of acute coronary syndromes. J Am Geriatr Soc 2011; 59: 506-511.
16. Gurwitz JH, Col NF, Avorn J,. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268: 1417-1422.
17. Bayer A, Tadd W,. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: Descriptive study. BMJ 2000; 321: 992-993.
18. Witham MD, McMurdo ME,. How to get older people included in clinical studies. Drugs Aging 2007; 24: 187-196.
19. Bartlett C, Doyal L, Ebrahim S, et al. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess 2005; 9:iii-iv, ix-x, 1-152.
20. Grant RW, Wexler DJ, Ashburner JM, et al. Characteristics of "complex" patients with type 2 diabetes mellitus according to their primary care physicians. Arch Intern Med 2012; 172: 821-823.
21. Umegaki H, Iimuro S, Shinozaki T, et al. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: Baseline data analysis of the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int 2012; 12 (Suppl 1): 103-109.
22. Ferrer A, Padros G, Formiga F, et al. Diabetes mellitus: Prevalence and effect of morbidities in the oldest old. The Octabaix Study. J Am Geriatr Soc 2012; 60: 462-467.
23. Kirchberger I, Meisinger C, Heier M, et al. Patterns of multimorbidity in the aged population. Results from the KORA-Age study. PLoS ONE 2012; 7: e30556.
24. Barzilai N, Guo H, Mahoney EM, et al. Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Curr Med Res Opin 2011; 27: 1049-1058.
25. Committee for Human Medicinal Products. European Medicines Agency. Adequacy of Guidance on the Elderly Regarding Medicinal Products for Human Use [on-line]. Available at www.ema.europa.eu/docs/en-GB/document-library/ Scientific-guideline/2010/01/WC500049541.pdf Accessed August 22, 2012.
26. Siu LL,. Clinical trials in the elderly-a concept comes of age. N Engl J Med 2007; 356: 1575-1576.